ホーム>Home>News> Our clinical research on gene therapy for familial LCAT deficiency syndrome, classified as Class I Regenerative Medicine, approved by MHLW.
Our clinical research on gene therapy for familial LCAT deficiency syndrome, classified as Class I Regenerative Medicine, approved by MHLW.